This paper is in the following e-collection/theme issue:

Psychotic Disorders (194) Mobile Health (mhealth) (3464) Mobile Health in Psychiatry (527) Formative Evaluation of Digital Health Interventions (3229) Digital Mental Health Interventions, e-Mental Health and Cyberpsychology (2111) Telepsychiatry (212) Innovations in Mental Health Systems (484) Prescribable Digital Interventions (Digital Therapeutics) (44) Theme issue 2019: The Digital Therapeutic Alliance (7)

Published on in Vol 12 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64959, first published .
Establishment and Maintenance of a Digital Therapeutic Alliance in People Living With Negative Symptoms of Schizophrenia: Two Exploratory Single-Arm Studies

Establishment and Maintenance of a Digital Therapeutic Alliance in People Living With Negative Symptoms of Schizophrenia: Two Exploratory Single-Arm Studies

Establishment and Maintenance of a Digital Therapeutic Alliance in People Living With Negative Symptoms of Schizophrenia: Two Exploratory Single-Arm Studies

Authors of this article:

Cassandra Snipes1 Author Orcid Image ;   Cornelia Dorner‑Ciossek2 Author Orcid Image ;   Brendan D Hare3 Author Orcid Image ;   Olya Besedina1 Author Orcid Image ;   Tim Campellone1 Author Orcid Image ;   Mariya Petrova1 Author Orcid Image ;   Shaheen E Lakhan4 Author Orcid Image ;   Abhishek Pratap3 Author Orcid Image
Article Authors Cited by (5) Tweetations Metrics

Journals

  1. Lakhan S. Introducing Digital Pharmacometrics: A Pharmacokinetics (PK)/Pharmacodynamics (PD) Framework for Prescription Digital Therapeutics. Cureus 2025 View
  2. Goenjian H, Pratap A, Snipes C, Hare B, Kantrowitz J, Dennis T, McNeel W, Ung E, Besedina O, Gupta A, Campellone T, Petrova M, Perocco S, Vaidyanathan U, Lakhan S, Dorner-Ciossek C. Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study. Schizophrenia 2025;11(1) View
  3. Lakhan S, Dorner-Ciossek C, Besedina O, Dickerson F, Hastedt C, Isla R, Kahn R, Lindenmayer J, Mehta R, Snipes C, Speier A, Tang W, Willis B, Fernandez J, von der Goltz C, Pratap A. Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial. JMIR Research Protocols 2025;14:e81293 View
  4. Xia W, Hau C, Firth J, Kimhy D, Torous J. Smartphone Apps and Digital Tools for Managing Schizophrenia and Psychotic Disorders: A Clinical Review. Focus 2025;23(4):419 View
  5. Gandhi A, Firmin R, Luther L, Wahid N, Parcher B, Brown J, Machniewska G, Hare B, Perocco S, Strauss G, Dorner-Ciossek C, Pratap A. Patient Perspectives on a Digital Therapeutic for Schizophrenia: A Qualitative Evaluation of an App for Negative Symptoms. Schizophrenia Bulletin Open 2025;6(1) View